Development of a novel next-generation multi-epitope vaccine targeting the Guaroa virus glycoprotein precursor through reverse vaccinology
Naunyn-Schmiedeberg's Archives of Pharmacology · 31.10.2026
DOI: 10.1007/s00210-026-06044-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 31.10.2026. Verfasst von Muhammad Asim und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Faculty of Science and Technology, University of Central Punjab, Lahore, Pakistan. muhammadasim4342@gmail.com. Die Arbeit nennt 68 Literaturangaben.
Abstract (Originalsprache)
This study aimed to develop a multi-epitope vaccine candidate against Guaroa virus using integrated immunoinformatics and reverse vaccinology approaches. The viral glycoprotein precursor was selected as the target for epitope screening. Potential B-cell and T-cell epitopes with predicted antigenic properties, non-allergenicity, and non-toxicity were identified through computational analyses. Global population coverage assessment predicted a population coverage of 99.09% based on the selected HLA-associated epitopes. Selected epitopes were assembled into a chimeric vaccine construct containing β-defensin-3 adjuvant and linker sequences. Physicochemical analysis predicted properties relevant to solubility and recombinant expression, although these characteristics require experimental assessment. Structural prediction and refinement yielded a model in which 99.5% of residues were located within favored regions. Molecular docking predicted interactions between the vaccine construct and immune receptors TLR2, TLR3, and TLR4, with TLR4 showing the lowest docking score among the three receptors. Molecular dynamics simulations were used to assess the predicted structural behavior of the vaccine–receptor complexes. The vaccine–TLR4 complex yielded a docking score of −1212.9, while MM-GBSA analysis produced a ΔG_bind estimate of −227.14 kcal/mol based on the final trajectory frame. Immune simulation predicted increases in antibody production, cytokine release, and memory cell formation. Collectively, these findings support the computational prioritization of the construct as a vaccine candidate for further experimental investigation, although experimental and clinical validation remain necessary.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biotechnology, Faculty of Science and Technology, University of Central Punjab, Lahore, Pakistan. muhammadasim4342@gmail.com.
- Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah, 51452, Saudi Arabia.
- Department of Biological Sciences, College of Science, King Faisal University, Al-Ahsa, 31982, Saudi Arabia. ryehia@kfu.edu.sa.
- Department of Biological Sciences, College of Science, King Faisal University, Al-Ahsa, 31982, Saudi Arabia.
- Department of Basic Health Sciences, College of Applied Medical Sciences, Qassim University, Buraydah, 51452, Saudi Arabia.
- Department of Biology, College of Science, Princess Nourah Bint Abdulrahman University, P.O. Box 84428, Riyadh, 11671, Saudi Arabia.
ORCID-Profile: Muhammad Asim
Zitieren
APA
Asim, M., Almatroudi, A., Yehia, R. S., Almustafa, H., Aljohani, W. A., Alrashedi, M., Alshuhayb, R., & Al-Megrin, W. A. I. (2026). Development of a novel next-generation multi-epitope vaccine targeting the Guaroa virus glycoprotein precursor through reverse vaccinology. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-026-06044-8
Vancouver
Asim M, Almatroudi A, Yehia RS, Almustafa H, Aljohani WA, Alrashedi M, et al. Development of a novel next-generation multi-epitope vaccine targeting the Guaroa virus glycoprotein precursor through reverse vaccinology. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-026-06044-8
BibTeX
@article{Asim2026,
author = {Asim, Muhammad and Almatroudi, Ahmad and Yehia, Ramy S and Almustafa, Hibah and Aljohani, Waad A and Alrashedi, Madhawi and Alshuhayb, Reem and Al-Megrin, Wafa Abdullah I},
title = {Development of a novel next-generation multi-epitope vaccine targeting the Guaroa virus glycoprotein precursor through reverse vaccinology},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2026},
doi = {10.1007/s00210-026-06044-8}
}
EUVIMED